Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Plymate

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2019
Clinical Significance of AR-V567es in Prostate Cancer-LetterTakuma Uo, Stephen R Plymate
Expert Opinion on Therapeutic Targets|August 6, 2016
Response: letter to the editorMichael T Schweizer, Stephen R Plymate
JAMA Oncology|June 5, 2016
AR-V7 Protein in Circulating Tumor Cells-The Decider for Therapy?R B Montgomery, Stephen R Plymate
Hormones & Cancer|May 7, 2014
The link between androgen receptor splice variants and castration-resistant prostate cancerCynthia C T Sprenger, Stephen R Plymate
Cell Reports. Medicine|March 4, 2022
Starving lethal prostate cancer by targeting heat shock proteins and glycolytic enzymesStephen R Plymate, Cynthia Sprenger, Michael C Haffner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 2018
AR-Variant-Positive CTC: A Surrogate for a Surrogate for Taxane Therapy Outcome?Scott M Dehm, Bruce Montgomery, Stephen R Plymate
Endocrine-Related Cancer|August 16, 2017
Allosteric alterations in the androgen receptor and activity in prostate cancerTakuma Uo, Stephen R Plymate, Cynthia C Sprenger
Expert Opinion on Therapeutic Targets|February 9, 2018
The potential of AR-V7 as a therapeutic targetTakuma Uo, Stephen R Plymate, Cynthia C Sprenger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2013
Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefitElahe A Mostaghel, Stephen R Plymate, Bruce Montgomery
Frontiers in Oncology|November 9, 2020
Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate CancerTakuma Uo, Cynthia C Sprenger, Stephen R Plymate
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2019
Clinical Significance of AR-V567es in Prostate Cancer-LetterTakuma Uo, Stephen R Plymate
Expert Opinion on Therapeutic Targets|August 6, 2016
Response: letter to the editorMichael T Schweizer, Stephen R Plymate
JAMA Oncology|June 5, 2016
AR-V7 Protein in Circulating Tumor Cells-The Decider for Therapy?R B Montgomery, Stephen R Plymate
Hormones & Cancer|May 7, 2014
The link between androgen receptor splice variants and castration-resistant prostate cancerCynthia C T Sprenger, Stephen R Plymate
Cell Reports. Medicine|March 4, 2022
Starving lethal prostate cancer by targeting heat shock proteins and glycolytic enzymesStephen R Plymate, Cynthia Sprenger, Michael C Haffner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 2018
AR-Variant-Positive CTC: A Surrogate for a Surrogate for Taxane Therapy Outcome?Scott M Dehm, Bruce Montgomery, Stephen R Plymate
Endocrine-Related Cancer|August 16, 2017
Allosteric alterations in the androgen receptor and activity in prostate cancerTakuma Uo, Stephen R Plymate, Cynthia C Sprenger
Expert Opinion on Therapeutic Targets|February 9, 2018
The potential of AR-V7 as a therapeutic targetTakuma Uo, Stephen R Plymate, Cynthia C Sprenger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2013
Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefitElahe A Mostaghel, Stephen R Plymate, Bruce Montgomery
Frontiers in Oncology|November 9, 2020
Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate CancerTakuma Uo, Cynthia C Sprenger, Stephen R Plymate
Pageof 12